COVID-19 Infection in Patients With Hepatocellular Carcinoma

Active, not recruitingOBSERVATIONAL
Enrollment

23

Participants

Timeline

Start Date

April 27, 2020

Primary Completion Date

October 1, 2023

Study Completion Date

October 31, 2024

Conditions
Hepatocellular CarcinomaCOVID-19
Interventions
DIAGNOSTIC_TEST

nasopharyngeal Covid 19 RT-PCR

nasopharyngeal Covid 19 RT-PCR

Trial Locations (1)

80480

CHU Amiens, Amiens

All Listed Sponsors
collaborator

Centre Hospitalier-Universitaire Bondy

UNKNOWN

collaborator

University Hospital, Bordeaux

OTHER

collaborator

Centre Hospitalier-Universitaire CLICHY

UNKNOWN

collaborator

Centre Hospitalier Général CORBEIL-ESSONNE

UNKNOWN

collaborator

CHU CRETEIL

UNKNOWN

collaborator

University Hospital, Grenoble

OTHER

collaborator

University Hospital, Lille

OTHER

collaborator

Hospices Civils de Lyon

OTHER

collaborator

Poitiers University Hospital

OTHER

collaborator

Rennes University Hospital

OTHER

collaborator

University Hospital, Rouen

OTHER

collaborator

University Hospital, Toulouse

OTHER

collaborator

CHU VILLEJUIF

UNKNOWN

collaborator

Central Hospital, Nancy, France

OTHER

collaborator

Centre Hospitalier Universitaire de Nice

OTHER

collaborator

University Hospital, Montpellier

OTHER

lead

Centre Hospitalier Universitaire, Amiens

OTHER

NCT04367805 - COVID-19 Infection in Patients With Hepatocellular Carcinoma | Biotech Hunter | Biotech Hunter